Avoid freehand biopsy errors
Avoid freehand biopsy errors
Early detection of malignant tumors
Easy guidance to target anterior lesions
Active surveillance & focal therapy
Reduce repeat biopsy sessions
Quick set-up & intuitive workflow
No sensor-based needle supplies
No specialized room
PACS, cloud & network connectivity
Compatible with all MRI and U/S systems
Seamless radiology-urology integration
Reduce unnecessary biopsy costs
Reduce unnecessary supply costs
Cost benefits of early detection of PCa
Increased patient satisfaction & retention
Protocol | Sensitivity | Specificity | Accuracy | AUC |
---|---|---|---|---|
T2W | 73% | 54% | 64% | 0.711 |
T2W + DWI | 84% | 85% | 84% | 0.905 |
T2W + DWI + DCE | 95% | 74% | 86% | 0.966 |
# Patients | 19 | 14 | 61 | 61 | 16 |
---|---|---|---|---|---|
# Any CaP | 6 | 6 | 29 | 34 | 15 |
Gleason ≥ CaP | 3 | 1 | 9 | 14 | 7 |